ID   KS6A1_HUMAN             Reviewed;         735 AA.
AC   Q15418; B2RDY8; Q5SVM5; Q5SVM8; Q5SVM9; Q96C05; Q9BQK2;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2002, sequence version 2.
DT   02-NOV-2010, entry version 113.
DE   RecName: Full=Ribosomal protein S6 kinase alpha-1;
DE            Short=S6K-alpha-1;
DE            EC=2.7.11.1;
DE   AltName: Full=90 kDa ribosomal protein S6 kinase 1;
DE            Short=p90-RSK 1;
DE            Short=p90RSK1;
DE            Short=p90S6K;
DE   AltName: Full=MAP kinase-activated protein kinase 1a;
DE            Short=MAPK-activated protein kinase 1a;
DE            Short=MAPKAP kinase 1a;
DE            Short=MAPKAPK-1a;
DE   AltName: Full=Ribosomal S6 kinase 1;
DE            Short=RSK-1;
GN   Name=RPS6KA1; Synonyms=MAPKAPK1A, RSK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-335.
RX   MEDLINE=94189676; PubMed=8141249;
RA   Moller D.E., Xia C.-H., Tang W., Zhu A.X., Jakubowski M.;
RT   "Human rsk isoforms: cloning and characterization of tissue-specific
RT   expression.";
RL   Am. J. Physiol. 266:C351-C359(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   MEDLINE=98353467; PubMed=9687510; DOI=10.1093/emboj/17.15.4426;
RA   Deak M., Clifton A.D., Lucocq J.M., Alessi D.R.;
RT   "Mitogen- and stress-activated protein kinase-1 (MSK1) is directly
RT   activated by MAPK and SAPK2/p38, and may mediate activation of CREB.";
RL   EMBO J. 17:4426-4441(1998).
RN   [7]
RP   FUNCTION, ENZYME REGULATION, AND PHOSPHORYLATION AT SER-221; THR-359;
RP   SER-363; SER-380; THR-573 AND SER-732.
RX   PubMed=9430688; DOI=10.1074/jbc.273.3.1496;
RA   Dalby K.N., Morrice N., Caudwell F.B., Avruch J., Cohen P.;
RT   "Identification of regulatory phosphorylation sites in mitogen-
RT   activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk
RT   that are inducible by MAPK.";
RL   J. Biol. Chem. 273:1496-1505(1998).
RN   [8]
RP   INTERACTION WITH MAPK1 OR MAPK3.
RX   PubMed=12832467; DOI=10.1128/MCB.23.14.4796-4804.2003;
RA   Roux P.P., Richards S.A., Blenis J.;
RT   "Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates
RT   extracellular signal-regulated kinase docking and RSK activity.";
RL   Mol. Cell. Biol. 23:4796-4804(2003).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-732, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Colon adenocarcinoma;
RX   PubMed=16083285; DOI=10.1021/pr050048h;
RA   Kim J.-E., Tannenbaum S.R., White F.M.;
RT   "Global phosphoproteome of HT-29 human colon adenocarcinoma cells.";
RL   J. Proteome Res. 4:1339-1346(2005).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-359 AND SER-363, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-221; THR-225; THR-359;
RP   SER-363; SER-369 AND SER-380, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-359; SER-363; SER-369;
RP   SER-380 AND THR-573, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-359; SER-363; SER-369;
RP   SER-380 AND THR-573, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-25; SER-26; SER-54;
RP   SER-72; THR-204; SER-209; TYR-220; SER-221; SER-307; THR-359; SER-363;
RP   SER-369; SER-380; THR-573; TYR-576; THR-635; SER-637; SER-684 AND
RP   SER-732, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-380, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-335.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine kinase that may play a role in
CC       mediating the growth-factor and stress induced activation of the
CC       transcription factor CREB.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by multiple phosphorylations on
CC       threonine and serine residues.
CC   -!- SUBUNIT: Forms a complex with either ERK1 or ERK2 in quiescent
CC       cells. Transiently dissociates following mitogenic stimulation.
CC   -!- INTERACTION:
CC       P16220:CREB1; NbExp=1; IntAct=EBI-963034, EBI-711855;
CC   -!- PTM: Autophosphorylated on Ser-380, as part of the activation
CC       process.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. S6 kinase subfamily.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 2 protein kinase domains.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/RPS6KA1ID43477ch1p36.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L07597; AAC82497.1; -; mRNA.
DR   EMBL; AK315730; BAG38085.1; -; mRNA.
DR   EMBL; AL109743; CAC36348.1; -; Genomic_DNA.
DR   EMBL; AL627313; CAI14647.1; -; Genomic_DNA.
DR   EMBL; AL627313; CAI14648.1; -; Genomic_DNA.
DR   EMBL; AL627313; CAI14649.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07799.1; -; Genomic_DNA.
DR   EMBL; BC014966; AAH14966.1; -; mRNA.
DR   IPI; IPI00017305; -.
DR   PIR; I51901; I51901.
DR   RefSeq; NP_001006666.1; -.
DR   RefSeq; NP_002944.2; -.
DR   UniGene; Hs.149957; -.
DR   PDB; 2WNT; X-ray; 2.40 A; A/B=413-719.
DR   PDB; 2Z7Q; X-ray; 2.00 A; A=33-353.
DR   PDB; 2Z7R; X-ray; 2.00 A; A=33-353.
DR   PDB; 2Z7S; X-ray; 2.10 A; A=33-353.
DR   PDBsum; 2WNT; -.
DR   PDBsum; 2Z7Q; -.
DR   PDBsum; 2Z7R; -.
DR   PDBsum; 2Z7S; -.
DR   ProteinModelPortal; Q15418; -.
DR   SMR; Q15418; 60-387.
DR   DIP; DIP-29987N; -.
DR   IntAct; Q15418; 1.
DR   MINT; MINT-207205; -.
DR   STRING; Q15418; -.
DR   PhosphoSite; Q15418; -.
DR   UCD-2DPAGE; Q15418; -.
DR   PRIDE; Q15418; -.
DR   Ensembl; ENST00000374168; ENSP00000363283; ENSG00000117676.
DR   GeneID; 6195; -.
DR   KEGG; hsa:6195; -.
DR   UCSC; uc001bmr.1; human.
DR   CTD; 6195; -.
DR   GeneCards; GC01P026856; -.
DR   H-InvDB; HIX0199893; -.
DR   HGNC; HGNC:10430; RPS6KA1.
DR   HPA; CAB003852; -.
DR   HPA; HPA007981; -.
DR   MIM; 601684; gene.
DR   PharmGKB; PA34845; -.
DR   eggNOG; prNOG09026; -.
DR   HOVERGEN; HBG108317; -.
DR   OrthoDB; EOG9V45T5; -.
DR   PhylomeDB; Q15418; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; fgf_pathway; FGF signaling pathway.
DR   Pathway_Interaction_DB; mapktrkpathway; Trk receptor signaling mediated by the MAPK pathway.
DR   Pathway_Interaction_DB; lymphangiogenesis_pathway; VEGFR3 signaling in lymphatic endothelium.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_13685; Synaptic Transmission.
DR   Reactome; REACT_18266; Axon guidance.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   BindingDB; Q15418; -.
DR   NextBio; 24057; -.
DR   ArrayExpress; Q15418; -.
DR   Bgee; Q15418; -.
DR   CleanEx; HS_RPS6KA1; -.
DR   Genevestigator; Q15418; -.
DR   GermOnline; ENSG00000117676; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; EXP:Reactome.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IEA:InterPro.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR016239; Ribosomal_S6_kinase_II.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 2.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000606; Ribsml_S6_kin_2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 2.
DR   SUPFAM; SSF56112; Kinase_like; 2.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 2.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 2.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 2.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Kinase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Repeat; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    735       Ribosomal protein S6 kinase alpha-1.
FT                                /FTId=PRO_0000086198.
FT   DOMAIN       62    321       Protein kinase 1.
FT   DOMAIN      322    391       AGC-kinase C-terminal.
FT   DOMAIN      418    675       Protein kinase 2.
FT   NP_BIND      68     76       ATP (By similarity).
FT   NP_BIND     424    432       ATP (By similarity).
FT   ACT_SITE    187    187       Proton acceptor (By similarity).
FT   ACT_SITE    535    535       Proton acceptor (By similarity).
FT   BINDING      94     94       ATP (By similarity).
FT   BINDING     447    447       ATP (By similarity).
FT   MOD_RES      25     25       Phosphothreonine.
FT   MOD_RES      26     26       Phosphoserine.
FT   MOD_RES      54     54       Phosphoserine.
FT   MOD_RES      72     72       Phosphoserine.
FT   MOD_RES     204    204       Phosphothreonine.
FT   MOD_RES     209    209       Phosphoserine.
FT   MOD_RES     220    220       Phosphotyrosine.
FT   MOD_RES     221    221       Phosphoserine.
FT   MOD_RES     225    225       Phosphothreonine.
FT   MOD_RES     307    307       Phosphoserine.
FT   MOD_RES     348    348       Phosphothreonine.
FT   MOD_RES     359    359       Phosphothreonine.
FT   MOD_RES     363    363       Phosphoserine.
FT   MOD_RES     369    369       Phosphoserine.
FT   MOD_RES     380    380       Phosphoserine; by autocatalysis.
FT   MOD_RES     573    573       Phosphothreonine.
FT   MOD_RES     576    576       Phosphotyrosine.
FT   MOD_RES     635    635       Phosphothreonine.
FT   MOD_RES     637    637       Phosphoserine.
FT   MOD_RES     684    684       Phosphoserine.
FT   MOD_RES     732    732       Phosphoserine.
FT   VARIANT     335    335       K -> T (in dbSNP:rs2229712).
FT                                /FTId=VAR_021864.
FT   HELIX        59     61
FT   STRAND       62     71
FT   STRAND       74     81
FT   STRAND       83     86
FT   STRAND       90     96
FT   STRAND      127    133
FT   STRAND      136    141
FT   HELIX       149    156
FT   HELIX       161    180
FT   HELIX       190    192
FT   STRAND      193    195
FT   STRAND      197    199
FT   STRAND      201    203
FT   HELIX       226    228
FT   HELIX       231    234
FT   HELIX       241    257
FT   HELIX       267    276
FT   HELIX       287    296
FT   TURN        301    303
FT   STRAND      307    310
FT   HELIX       312    316
FT   HELIX       319    321
FT   HELIX       326    330
SQ   SEQUENCE   735 AA;  82723 MW;  765731A4442A53DF CRC64;
     MPLAQLKEPW PLMELVPLDP ENGQTSGEEA GLQPSKDEGV LKEISITHHV KAGSEKADPS
     HFELLKVLGQ GSFGKVFLVR KVTRPDSGHL YAMKVLKKAT LKVRDRVRTK MERDILADVN
     HPFVVKLHYA FQTEGKLYLI LDFLRGGDLF TRLSKEVMFT EEDVKFYLAE LALGLDHLHS
     LGIIYRDLKP ENILLDEEGH IKLTDFGLSK EAIDHEKKAY SFCGTVEYMA PEVVNRQGHS
     HSADWWSYGV LMFEMLTGSL PFQGKDRKET MTLILKAKLG MPQFLSTEAQ SLLRALFKRN
     PANRLGSGPD GAEEIKRHVF YSTIDWNKLY RREIKPPFKP AVAQPDDTFY FDTEFTSRTP
     KDSPGIPPSA GAHQLFRGFS FVATGLMEDD GKPRAPQAPL HSVVQQLHGK NLVFSDGYVV
     KETIGVGSYS ECKRCVHKAT NMEYAVKVID KSKRDPSEEI EILLRYGQHP NIITLKDVYD
     DGKHVYLVTE LMRGGELLDK ILRQKFFSER EASFVLHTIG KTVEYLHSQG VVHRDLKPSN
     ILYVDESGNP ECLRICDFGF AKQLRAENGL LMTPCYTANF VAPEVLKRQG YDEGCDIWSL
     GILLYTMLAG YTPFANGPSD TPEEILTRIG SGKFTLSGGN WNTVSETAKD LVSKMLHVDP
     HQRLTAKQVL QHPWVTQKDK LPQSQLSHQD LQLVKGAMAA TYSALNSSKP TPQLKPIESS
     ILAQRRVRKL PSTTL
//
